SEC Form D · Amendment · filed May 2, 2017
Cingulate Therapeutics
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (23)
Shane J. Schaffer · Leawood, KSExecPatrick J. Gallagher · Flanders, NJDirectorRaul R. Silva · Upper Grandview, NYExecLaurie A. Myers · Lawrenceville, NJDirectorCraig S. Gilgallon · Morristown, NJExecArthur B. Straughn · Cordova, TNDirectorMatthew N. Brams · Houston, TXDirectorThomas J. Marusak · Albany, NYDirectorMarious 5. Sjulsen · New York, NYExecDavid C. Michaels · Albany, NYDirectorJames A. Henderson · New York, NYDirectorAnton P. Feingold · New York, NYExecWilliam P. Phelan · Albany, NYExecJeff Kellam · Longview, TXDirectorCraig S. Tashjy · Morristown, NJExecGeorge A. Overholser · KIRKLAND, WADirectorJohn H. Cox · Schaumburg, ILExecArrun Kapoor · Durham, NCDirectorAlan Kelley · Durham, NCDirectorMark H. Sherman · Tiburon, CAExecRonnie Wallace · Rome, GADirectorBryan Kelley · Rome, GAExecCraig S. Tashjy · chester, NJExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗